Results 161 to 170 of about 53,065 (244)

Unique Presentation of Adult Ileocecal Intussusception Unveiling a Rare Culprit: A Carcinoid Tumor. [PDF]

Cureus
Zammit CM, Munz ML, Tjiattas-Saleski L, Knolhoff J.   +3 more
europepmc   +1 more source

Horizontal partial laryngectomy for laryngeal neuroendocrine tumor: A case report. [PDF]

Int J Surg Case Rep
Kashima K, Igarashi T, Fujii H, Fukushima N, Nishino H, Kanazawa T.   +5 more
europepmc   +1 more source

Burden of Comorbidities and Concomitant Medications and Their Associated Costs in Patients with Gastroenteropancreatic or Lung Neuroendocrine Tumors: Analysis of US Administrative Data. [PDF]

Adv Ther
Chan JA, Ribeiro-Oliveira A, Houchard A, Dennen S, Liu Y, Naga SSB, Zhao Y, Pommie C, Vandamme T, Starr J.   +9 more
europepmc   +1 more source

Unusual Cause of Wheezing in a Middle-Aged Woman: A Case Report. [PDF]

Cureus
Karimi R, Adlakha A.
europepmc   +1 more source

Gastric Neuroendocrine Tumors and Pernicious Anemia: A Case Report and Literature Review. [PDF]

Cureus
Rudolph JJ, Agyei O, Telvizian T, Ghaneie A.   +3 more
europepmc   +1 more source

A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome [PDF]

Cancer, 1991
Sixteen patients with metastatic neuroendocrine tumors and the malignant carcinoid syndrome were treated with cyproheptadine (Periactin, Merck, Sharp & Dohme, West Point, PA) at maximum tolerable doses that ranged from 12 to 48 mg daily. Usual side effects were mild sedation and dry mouth, but three patients found it impossible to sustain treatment due
Charles G. Moertel, Joseph Rubin, Larry K. Kvols   +2 more
semanticscholar   +5 more sources

Malignant Carcinoid Syndrome

Archives of Surgery, 1959
The malignant carcinoid syndrome is manifested by (1) paroxysmal flushing, (2) chronic diarrhea, (3) respiratory distress, and (4) valvular heart disease. These abnormalities result from a marked increase in the amount of circulating serotonin. The abnormal clinical findings in this syndrome result principally from the action of serotonin on the ...
Wilson, Harwell, Storer, Edward H.
semanticscholar   +6 more sources

Results of Pharmacologic Treatment in the Malignant Carcinoid Syndrome

New England Journal of Medicine, 1962
THE patient with the malignant carcinoid syndrome is confronted with a group of uncomfortable and debilitating symptoms. These may include recurrent acute flushing, colicky abdominal pains, violent and profuse watery diarrhea, tachycardia, asthma-like wheezing and, less often, profound weakness, depression or agitation, dyspnea and dependent edema ...
Alvin L. Ureles, Robert E. Wolf, Martin Murray   +2 more
semanticscholar   +5 more sources

Effect of Melphalan in the Malignant Carcinoid Syndrome

Archives of Internal Medicine, 1969
Nine trials of the antitumor chemotherapeutic agent, melphalan (L-phenylalanine mustard; Alkeran) were carried out in eight patients with the malignant carcinoid syndrome. In six trials, this drug was given on a low-dose, daily basis. In three of these trials, there was definite evidence of antitumor effect as determined by measurable decreases in ...
Charles A. Lotito, Charles E. Mengel
semanticscholar   +5 more sources

Therapy of the Malignant Carcinoid Syndrome

Annals of Internal Medicine, 1965
Excerpt The therapy of the malignant carcinoid syndrome presents a unique challenge to physicians caring for patients with this unusual disease.
Charles E. Mengel
semanticscholar   +5 more sources